| Melissa M Mahon, CRNA/ARNP | |
|
105 E Locust St, Bloomfield, IA 52537-0054 | |
| (641) 664-3602 | |
| (641) 664-3765 |
| Full Name | Melissa M Mahon |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 105 E Locust St, Bloomfield, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003047820 | NPI | - | NPPES |
| PENDING | Other | FL | BCBS |
| PENDING | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP9207011 (Florida) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | D-129549 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson County Health Center | Fairfield, IA | Hospital |
| Henry County Health Center | Mount pleasant, IA | Hospital |
| Ottumwa Regional Health Center | Ottumwa, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bloomfield Anesthetists | 1557529948 | 11 |
| Henry County Health Center Inc | 9638570740 | 20 |
| Jefferson County Hospital | 9335059575 | 41 |
| Southeast Iowa Regional Medical Center Inc | 3870496417 | 189 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Jefferson County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881294536 PECOS PAC ID: 9335059575 Enrollment ID: O20031223000606 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20040130000139 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Wayne County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174599468 PECOS PAC ID: 4082508734 Enrollment ID: O20040212000233 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Mercy Medical Center-centerville |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528018801 PECOS PAC ID: 9739077652 Enrollment ID: O20040310000762 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Davis County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1942255666 PECOS PAC ID: 3971493040 Enrollment ID: O20061129000182 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Van Buren County Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1508810714 PECOS PAC ID: 7214829530 Enrollment ID: O20100908000821 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Bloomfield Anesthetists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811091390 PECOS PAC ID: 1557529948 Enrollment ID: O20120214000539 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Entity Name | Henry County Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871177477 PECOS PAC ID: 9638570740 Enrollment ID: O20210701003616 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melissa M Mahon, CRNA/ARNP Po Box 54, Bloomfield, IA 52537-0054 Ph: (641) 664-3602 | Melissa M Mahon, CRNA/ARNP 105 E Locust St, Bloomfield, IA 52537-0054 Ph: (641) 664-3602 |
News Archive
Despite current guidelines that recommend newly diagnosed high-cholesterol patients have a TSH blood test done to make sure they do not have hypothyroidism, researchers from Boston University School of Medicine and Boston Medical Center have found that only about half of these patients were screened for thyroid dysfunction.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models.
An Ohio State University molecular biologist leveraged a supercomputer to help better define the family tree of a group of enzymes that have been implicated in a wide range of human diseases and are important targets for anti-cancer therapies.
On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity's novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug discovery and development process.
There is a higher number of poor people in eight Indian states than in 26 of the poorest African countries, according to the Multidimensional Poverty Index, which was developed by the Oxford Poverty and Human Development Initiative with support from the U.N., the BBC reports (7/13).
› Verified 5 days ago
Valerie K Mckinley, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Mrs. Sara Katherine Mullahy, CRNA, ARNP Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Jay R Brewer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Jackie K Lauer, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 505 W Jefferson St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 | |
Mr. Mark James Gallion, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 105 E Locust St, Bloomfield, IA 52537 Phone: 641-664-3602 | |
Marty J Owen, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 505 W Jefferson St, Bloomfield, IA 52537 Phone: 641-664-3602 Fax: 641-664-3765 |